121 related articles for article (PubMed ID: 10148570)
1. Safety of heparin-coated circuits in primates during deep hypothermic cardiopulmonary bypass.
Sistino JJ; Michler RE; Mongero LB; Schwartz A; Marboe C; Geiman R; Kwiatkowski P
J Extra Corpor Technol; 1993; 25(1):15-21. PubMed ID: 10148570
[TBL] [Abstract][Full Text] [Related]
2. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
[TBL] [Abstract][Full Text] [Related]
3. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R
Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142
[TBL] [Abstract][Full Text] [Related]
4. Cardiopulmonary bypass without systemic heparinization. Performance of heparin-coated oxygenators in comparison with classic membrane and bubble oxygenators.
von Segesser LK; Turina M
J Thorac Cardiovasc Surg; 1989 Sep; 98(3):386-96. PubMed ID: 2770320
[TBL] [Abstract][Full Text] [Related]
5. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
[TBL] [Abstract][Full Text] [Related]
6. The effect of hypothermic cardiopulmonary bypass and total circulatory arrest on cerebral metabolism in neonates, infants, and children.
Greeley WJ; Kern FH; Ungerleider RM; Boyd JL; Quill T; Smith LR; Baldwin B; Reves JG
J Thorac Cardiovasc Surg; 1991 May; 101(5):783-94. PubMed ID: 2023435
[TBL] [Abstract][Full Text] [Related]
7. Clinical study of biocompatibility between open and closed heparin-coated cardiopulmonary bypass circuits.
Tanaka H; Oshiyama T; Narisawa T; Mori T; Masuda M; Kishi D; Kitou T; Miyazima S
J Artif Organs; 2003; 6(4):245-52. PubMed ID: 14691666
[TBL] [Abstract][Full Text] [Related]
8. Reduction and elimination of systemic heparinization during cardiopulmonary bypass.
von Segesser LK; Weiss BM; Garcia E; von Felten A; Turina MI
J Thorac Cardiovasc Surg; 1992 Apr; 103(4):790-8; discussion 798-9. PubMed ID: 1548923
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
[TBL] [Abstract][Full Text] [Related]
10. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Matsukawa R; Kawashima Y
Circulation; 1997 Nov; 96(9 Suppl):II-376-81. PubMed ID: 9386127
[TBL] [Abstract][Full Text] [Related]
11. Maintenance of blood heparin concentration rather than activated clotting time better preserves the coagulation system in hypothermic cardiopulmonary bypass.
Shirota K; Watanabe T; Takagi Y; Ohara Y; Usui A; Yasuura K
Artif Organs; 2000 Jan; 24(1):49-56. PubMed ID: 10677157
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of the effect on clinical outcome of the use of an open circuit and the use of a closed circuit in cardiopulmonary bypass for a graft replacement of the descending thoracic or thoracoabdominal aorta.
Fukada J; Morishita K; Ingu A; Kawaharada N; Fujisawa Y; Hasegawa T; Abe T
Surg Today; 2004; 34(1):11-5. PubMed ID: 14714222
[TBL] [Abstract][Full Text] [Related]
13. Deep hypothermic circulatory arrest and global reperfusion injury: avoidance by making a pump prime reperfusate--a new concept.
Allen BS; Veluz JS; Buckberg GD; Aeberhard E; Ignarro LJ
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):625-32. PubMed ID: 12658205
[TBL] [Abstract][Full Text] [Related]
14. Clinical heparin coated cardiopulmonary bypass: reduction of systemic heparin requirements for redo cardiac surgery.
Ladowski JS; Schatzlein MH; Peterson AC; Deschner WP; Matheis R; Ellenwood M; Bach J; Moldovan L; McKamey D
ASAIO J; 1996; 42(1):34-6. PubMed ID: 8808455
[TBL] [Abstract][Full Text] [Related]
15. Effects of moderate versus deep hypothermic circulatory arrest and selective cerebral perfusion on cerebrospinal fluid proteomic profiles in a piglet model of cardiopulmonary bypass.
Allibhai T; DiGeronimo R; Whitin J; Salazar J; Yu TT; Ling XB; Cohen H; Dixon P; Madan A
J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1290-6. PubMed ID: 19660276
[TBL] [Abstract][Full Text] [Related]
16. [The evaluation of the bio-compatibility and the clinical usefulness of heparin-coated cardiopulmonary bypass circuits].
Yamanaka J; Takeuchi Y; Torii S; Gomi A; Nakatani H; Kohno K
Nihon Kyobu Geka Gakkai Zasshi; 1996 Jan; 44(1):47-53. PubMed ID: 8683171
[TBL] [Abstract][Full Text] [Related]
17. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose.
Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C
Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424
[TBL] [Abstract][Full Text] [Related]
18. The effects of deep hypothermic cardiopulmonary bypass and total circulatory arrest on cerebral blood flow in infants and children.
Greeley WJ; Ungerleider RM; Smith LR; Reves JG
J Thorac Cardiovasc Surg; 1989 May; 97(5):737-45. PubMed ID: 2709864
[TBL] [Abstract][Full Text] [Related]
19. Biocompatibility reflected by haemostasis variables during cardiopulmonary bypass using heparin-coated circuits.
Borowiec J; Bagge L; Saldeen T; Thelin S
Thorac Cardiovasc Surg; 1997 Aug; 45(4):163-7. PubMed ID: 9323816
[TBL] [Abstract][Full Text] [Related]
20. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M
Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
